Scientists Testing Inhaler Protection Against the Coronavirus

September 16, 2020

As the world waits for the development of an immunization to give people immunity against COVID-19, scientists at University of California in San Francisco are looking to test an aerosol which they believe can protect users from the coronavirus.

Users could self-administer the aerosol, dubbed “AeroNabs,” through a nasal spray or inhaler. Used once a day, it could provide protection against SARS-CoV-2 until a vaccine becomes available. The research team is in active discussions with commercial partners to ramp up manufacturing and clinical testing of AeroNabs, which they describe as “molecular personal protective equipment (PPE).”

The coronavirus invades hosts through its spikes. These spikes can switch from a closed, inactive state to an open, active state, during which it can attach to human cells that line the lung and airway. The aerosol works by disabling the spikes, thereby preventing the virus from infecting hosts.

Latest Articles

Linda Lybert
January 29, 2026 Jeff Cross

Where Collaboration Turns Into Action: Inside the Healthcare Surfaces Summit 2026

January 29, 2026 Elizabeth Christenson

Battling Superbugs in Healthcare Settings

January 26, 2026 Jeff Cross

Don’t Get Stuck in the Friend Zone

Sponsored Articles

Tru-D Care
January 7, 2026 Sponsored by Tru-D

Inside Tru-D SmartUVC: The Importance of Service and Upkeep for UVC Disinfection

January 7, 2026 Sponsored by PDI

One Wipe. One Minute. One Solution. PDI Raises the Standard for Infection Prevention

December 15, 2025 Sponsored by Novonesis

Inside the Art of Cleaning—and What Happens When It Fails

Recent News

child with measles

South Carolina Measles Cases Surpass Last Year’s Texas Outbreak

Register Today for CMM’s Webinar: Virus Busters

Doctors Issue Vaccine Recommendations That Differ From CDC